Neurology News

The American Academy of Neurology has issued a statement in support of protections surrounding the physician-patient relationship, following the U.S. Supreme Court’s decision to overturn Roe v. Wade.

Individuals aged 65 years and older with a history of hypothyroidism were associated with an 81% increased risk for dementia, researchers reported in Neurology.

Drugs that target the noradrenergic system may improve cognition and apathy in patients with dementia or mild cognitive impairment caused by Alzheimer’s disease but have little effect on attention or episodic memory, researchers reported.

Analyzing clinical phenotypes of race, ethnicity and sex, as well as history of concussions and depression, were crucial in determining risk for suicide attempts among youth in the United States, a study showed in JAMA Network Open.

Antibodies produced in response to COVID-19 may mistakenly target cells essential to the blood-brain barrier, which can cause bleeds and clots in patients and increase the risk for stroke, researchers reported in Brain.

The Parkinson’s Foundation has announced the expansion of its global care network with the addition of four Centers of Excellence and six Comprehensive Care Centers to increase access to high-quality care throughout the United States.

Gene therapy company uniQure has announced safety and biomarker data from 10 patients enrolled in the low-dose cohort of the ongoing phase 1/2 clinical trial of AMT-130 for treatment of Huntington’s disease.

Headache-related disability and PTSD symptom severity improved with cognitive behavioral therapy compared with usual care in United States military veterans with posttraumatic headache and PTSD, according to a study in JAMA Neurology.

PTSD was associated with accelerated decline in cognitive function in middle-aged women, researchers reported in JAMA Network Open.

Continuous subcutaneous infusion of foslevodopa/foscarbidopa was safe and improved motor complications in patients with advanced Parkinson’s disease, according to data presented at the European Academy of Neurology Congress 2022.